GlassScriptPhysician profile
Elliott C Silbar
NPI 1346231339
$2,545.45
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $572 · 2021: $592 · 2022: $88.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $555.31 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $339.96 | 2019-2021 | |
| Neotract INC. | $237.18 | 2019-2020 | |
| Janssen Biotech, INC. | $213.93 | 2019-2021 | |
| Pfizer INC. | $146.03 | 2019-2021 | |
| Medtronic USA, INC. | $141.64 | 2019-2020 | |
| Coloplast Corp | $138.26 | 2019-2021 | |
| Rochester Medical Corporation | $131.46 | 2021-2022 | |
| Abbvie INC. | $117.89 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $110.57 | 2019 | |
| 180 Medical, INC. | $62.58 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $61.63 | 2020-2021 | |
| Amgen INC. | $48.42 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $45.66 | 2019-2020 | |
| Urogen Pharma, INC. | $32.74 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.64 | 2019-2021 | |
| Medtronic, INC. | $22.56 | 2021 | |
| Procept Biorobotics Corporation | $20.35 | 2021 | |
| Blue Earth Diagnostics | $20.01 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.89 | 2019 | |
| Axonics, INC. | $15.65 | 2021 | |
| Myovant Sciences INC. | $13.78 | 2021 | |
| Cook Medical LLC | $13.38 | 2021 | |
| Mission Pharmacal Company | $11.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Silbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.